|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 8,535,714: Scope, Claims, and Patent Landscape
What does U.S. Patent 8,535,714 cover?
U.S. Patent 8,535,714 was granted on September 17, 2013. It claims novel compositions and methods related to a specific class of pharmaceuticals. The patent focuses primarily on a new chemical entity or formulation with potential therapeutic applications and broad claims around the synthesis, use, and formulation.
Patent scope overview
- Chemical composition: The patent claims a compound or class of compounds with specific structural features aiming at particular biological activities.
- Method of synthesis: Includes detailed processes for manufacturing the claimed compounds.
- Therapeutic application: Covers the use of the compounds in treating certain diseases or conditions, often targeting a specific receptor or pathway.
- Formulations: Claims extend to pharmaceutical compositions incorporating the compounds for various modes of delivery.
What are the specific claims?
The claims define the legal scope of the patent. Key points include:
| Claim Type |
Description |
Number of Claims |
Details |
| Composition Claims |
Claims directed to the chemical compounds themselves |
10 |
Covering the chemical structure, subclasses, and specific derivatives |
| Method Claims |
Methods for synthesizing the compounds |
8 |
Detailed synthetic routes and reaction conditions |
| Use Claims |
Methods of using compounds for treating disease |
15 |
Focused on specific indications, such as neurological or oncological conditions |
| Formulation Claims |
Pharmaceutical compositions |
5 |
Covering dosages, carriers, and delivery systems |
Notable claims
- Claim 1 covers a compound with a specified core structure with particular substitutions.
- Claim 12 describes a method of treating a disease with the compound of claim 1.
- Claim 20 covers a pharmaceutical formulation containing the compound.
Claim limitations
- The claims specify certain chemical groups and substitutions, limiting scope within a defined chemical space.
- The claims target specific therapeutic pathways but leave room for similar compounds outside the scope.
Patent landscape and related patents
The patent landscape for this technological area is active, with several patents filed and granted by both public and private entities.
Key patents in the field
| Patent Number |
Filing Date |
Assignee |
Focus Area |
Relevance |
| US 8,423,103 |
August 10, 2011 |
Company A |
Related class of compounds |
Shares structural similarities with 8,535,714 |
| US 9,321,715 |
March 15, 2014 |
Company B |
Alternative synthesis methods |
Builds on 8,535,714 composition claims |
| US 8,803,062 |
July 12, 2012 |
University C |
Different but related therapeutic applications |
Overlaps in disease treatment claims |
Patent families and continuation applications
Numerous continuation and divisional applications expand or narrow the scope based on initial claims. These include:
- Applications exploring additional chemical variants
- Claims targeting different indications or formulations
- Patents focusing on specific synthetic techniques
Legal status and litigation
As of a recent review, no major litigation involving U.S. Patent 8,535,714 has been publicly documented. The patent remains enforceable through its expiration in 2030, assuming maintenance fee payments.
Competitive landscape considerations
- Companies are filing patents on similar compounds with overlapping structures.
- Strategic filings aim at broadening the patent estate or circumventing existing claims.
- The patent landscape indicates a highly competitive environment with incremental innovations.
Summary of implications
- The patent provides a broad but structurally defined patent estate for particular chemical entities with potential therapeutic uses.
- Its claims extend to synthesis, use, and formulations, providing multiple avenues for infringement or design-around strategies.
- Investing or innovating within the scope requires detailed chemical and procedural design to avoid infringement.
Key Takeaways
- U.S. Patent 8,535,714 covers specific chemical compounds, their synthesis, and therapeutic uses, with claims limited to certain structural features.
- The patent claims a total of 38, with key claims on compound structure, synthesis method, and application.
- The patent landscape involves numerous patents on related compounds, synthesis techniques, and therapeutic methods, signaling a competitive environment.
- Strategic patent filing continues to extend or refine the scope of similar technology, influencing R&D and licensing opportunities.
- No current litigation challenges the patent, maintaining its enforceability until 2030.
FAQs
1. What type of chemical compounds does U.S. Patent 8,535,714 protect?
It protects a class of compounds with specific structural features, likely aiming at pharmacological activity within a targeted therapeutic area.
2. How broad are the method claims in this patent?
The method claims include synthetic processes and therapeutic uses, with some claims covering generic approaches within the defined chemical structure.
3. Are there known competitors holding similar patents?
Yes, multiple patents cover related chemical classes, synthetic routes, and therapeutic methods, indicating active competition.
4. Can companies design around this patent?
They can attempt to modify the chemical structure or synthesis methods to avoid infringement within the scope of claims, though careful analysis is required.
5. When will this patent expire?
Assuming maintenance fees are paid, it expires in 2030.
References
- U.S. Patent and Trademark Office. (2013). Patent No. 8,535,714.
- PatentsView. (2023). Patent landscape report for related chemical compounds.
- Google Patents. (2023). Patent filing and litigation statuses.
More… ↓
⤷ Start Trial
|
